ADAMS MICHAEL F 4
4 · AdvanSource Biomaterials Corp · Filed Dec 6, 2019
Insider Transaction Report
Form 4
ADAMS MICHAEL F
DirectorPresident and CEO
Transactions
- Exercise of In-Money
Common Stock
2019-12-05$0.06/sh+300,000$18,000→ 909,934 total - Exercise of In-Money
Common Stock
2019-12-05$0.06/sh+2,083,333$125,000→ 2,993,267 total - Exercise of In-Money
Common Stock
2019-12-05+291,667→ 3,284,934 total
Footnotes (3)
- [F1]Shares acquired from exercise of stock options granted pursuant to the 2003 Stock Option Plan in consideration for cash at an exercise price of $0.06 per share.
- [F2]Shares acquired from the exercise of options granted pursuant to the 2017 Non-Qualified Equity Incentive Plan in consideration for cash at an exercise price of $0.06 per share.
- [F3]Shares acquired from the exercise of options pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 416,667 shares of the Company's common stock at an exercise price of $0.06 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 291,667 shares, net.